[1] Puelacher C, Bollen Pinto B, Mills NL, et al. Expert consensus on peri-operative myocardial injury screening in noncardiac surgery: a literature review. Eur J Anaesthesiol 2021; 38: 600−608. doi: 10.1097/EJA.0000000000001486 [2] Pannell LM, Reyes EM, Underwood SR. Cardiac risk assessment before non-cardiac surgery. Eur Heart J Cardiovasc Imaging 2013; 14: 316−322. doi: 10.1093/ehjci/jes288 [3] Devereaux PJ, Biccard BM, Sigamani A, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2017; 317: 1642−1651. doi: 10.1001/jama.2017.4360 [4] Damani S, Bacconi A, Libiger O, et al. Characterization of circulating endothelial cells in acute myocardial infarction. Sci Transl Med 2012; 4: 126ra33. doi: 10.1126/scitranslmed.3003451 [5] Ruetzler K, Smilowitz NR, Berger JS, et al. Diagnosis and management of patients with myocardial injury after noncardiac surgery: a scientific statement from the American Heart Association. Circulation 2021; 144: e287−e305. doi: 10.1161/CIR.0000000000001024 [6] Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med 2015; 373: 2258−2269. doi: 10.1056/NEJMra1502824 [7] Woo SH, Marhefka GD, Cowan SW, et al. Development and validation of a prediction model for stroke, cardiac, and mortality risk after non-cardiac surgery. J Am Heart Assoc 2021; 10: e018013. doi: 10.1161/JAHA.120.018013 [8] Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043−1049. doi: 10.1161/01.CIR.100.10.1043 [9] Liu LY, Liu ZJ, Xu GY, et al. [Clinical utility of revised cardiac risk index to predict perioperative cardiac events in elderly patients with coronary heart disease undergoing non-cardiac surgery]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2020; 42: 732−739. [In Chinese]. doi: 10.3881/j.issn.1000-503X.12635 [10] Che L, Xu L, Huang Y, et al. Clinical utility of the revised cardiac risk index in older Chinese patients with known coronary artery disease. Clin Interv Aging 2017; 13: 35−41. doi: 10.2147/CIA.S144832 [11] Gong X, Zhang T, Feng S, et al. Association between N-terminal pro-BNP and 12 months major adverse cardiac events among patients admitted with NSTEMI. Ann Palliat Med 2021; 10: 5231−5243. doi: 10.21037/apm-20-2538 [12] Panagopoulou V, Deftereos S, Kossyvakis C, et al. NT-proBNP: an important biomarker in cardiac diseases. Curr Top Med Chem 2013; 13: 82−94. doi: 10.2174/1568026611313020002 [13] Yu W, Huang C, Wang Q, et al. Plasma BNP level combined with surgical Apgar score to predict operative major cardiac adverse events in malignant obstructive jaundice patients. Pak J Med Sci 2016; 32: 1188−1193. doi: 10.12669/pjms.325.10302 [14] Khan A, Johnson DK, Carlson S, et al. NT-proBNP predicts myocardial injury post-vascular surgery and is reduced with CoQ10: a randomized double-blind trial. Ann Vasc Surg 2020; 64: 292−302. doi: 10.1016/j.avsg.2019.09.017 [15] Verwijmeren L, Bosma M, Vernooij LM, et al. Associations between preoperative biomarkers and cardiac surgery-associated acute kidney injury in elderly patients: a cohort study. Anesth Analg 2021; 133: 570−577. doi: 10.1213/ANE.0000000000005650 [16] Szczeklik W, LeManach Y, Fronczek J, et al. Preoperative levels of natriuretic peptides and the incidence of postoperative atrial fibrillation after noncardiac surgery: a prospective cohort study. CMAJ 2020; 192: E1715−E1722. doi: 10.1503/cmaj.200840 [17] Duceppe E, Patel A, Chan MTV, et al. Preoperative N-terminal pro-B-type natriuretic peptide and cardiovascular events after noncardiac surgery: a cohort study. Ann Intern Med 2020; 172: 96−104. doi: 10.7326/M19-2501 [18] Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2014; 64: e77−e137. doi: 10.1016/j.jacc.2014.07.944 [19] Sessler DI, Bloomstone JA, Aronson S, et al. Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth 2019; 122: 563−574. doi: 10.1016/j.bja.2019.01.013 [20] Ram E, Sternik L, Klempfner R, et al. Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery. Cardiovasc Diabetol 2020; 19: 86. doi: 10.1186/s12933-020-01069-6 [21] Zhao X, Gao C, Dai F, et al. Treatments associated with lower mortality among critically ill COVID-19 patients: a retrospective cohort study. Anesthesiology 2021; 135: 1076−1090. doi: 10.1097/ALN.0000000000003999 [22] Feringa HH, Schouten O, Dunkelgrun M, et al. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery. Heart 2007; 93: 226−231. doi: 10.1136/hrt.2006.093716 [23] Wang C, Gao Y, Tian Y, et al. Prediction of acute kidney injury after cardiac surgery from preoperative N-terminal pro-B-type natriuretic peptide. Br J Anaesth 2021; 127: 862−870. doi: 10.1016/j.bja.2021.08.015 [24] Zhao BC, Zhuang PP, Lei SH, et al. Pre-operative N-terminal pro-B-type natriuretic peptide for prediction of acute kidney injury after noncardiac surgery: a retrospective cohort study. Eur J Anaesthesiol 2021; 38: 591−599. doi: 10.1097/EJA.0000000000001495 [25] Yun KH, Jeong MH, Oh SK, et al. Preoperative plasma N-terminal pro-brain natriuretic peptide concentration and perioperative cardiovascular risk in elderly patients. Circ J 2008; 72: 195−199. doi: 10.1253/circj.72.195 [26] Ma J, Xin Q, Wang X, et al. Prediction of perioperative cardiac events through preoperative NT-pro-BNP and cTnI after emergent non-cardiac surgery in elderly patients. PLoS One 2015; 10: e0121306. doi: 10.1371/journal.pone.0121306 [27] Farzi S, Stojakovic T, Marko T, et al. Role of N-terminal pro-B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgery. Br J Anaesth 2013; 110: 554−560. doi: 10.1093/bja/aes454 [28] Chong CP, Ryan JE, van Gaal WJ, et al. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery. Am J Cardiol 2010; 106: 865−872. doi: 10.1016/j.amjcard.2010.05.012 [29] Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002; 39: 542−553. doi: 10.1016/S0735-1097(01)01788-0 [30] Kopec M, Duma A, Helwani MA, et al. Improving prediction of postoperative myocardial infarction with high-sensitivity cardiac troponin T and NT-proBNP. Anesth Analg 2017; 124: 398−405. doi: 10.1213/ANE.0000000000001736 [31] Choi JH, Cho DK, Song YB, et al. Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery. Heart 2010; 96: 56−62. doi: 10.1136/hrt.2009.181388